Upregulation of ENAH by a PI3K/AKT/β-catenin cascade promotes oral cancer cell migration and growth via an ITGB5/Src axis
Oral cancer accounts for 2% of cancer-related deaths globally, with over 90% of cases being oral cavity squamous cell carcinomas (OSCCs). Approximately 50% of patients with OSCC succumb to the disease within 5 years, primarily due to the advanced stage at which it is typically diagnosed. This unders...
Saved in:
Published in | Cellular & molecular biology letters Vol. 29; no. 1; pp. 136 - 25 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central
07.11.2024
BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Oral cancer accounts for 2% of cancer-related deaths globally, with over 90% of cases being oral cavity squamous cell carcinomas (OSCCs). Approximately 50% of patients with OSCC succumb to the disease within 5 years, primarily due to the advanced stage at which it is typically diagnosed. This underscores an urgent need to identify proteins related to OSCC progression to develop effective diagnostic and therapeutic strategies.
To identify OSCC progression-related proteins, we conducted integrated proteome and transcriptome analyses on cancer tissues from patients and patient-derived xenograft (PDX) model mice. We investigated the role of protein-enabled homolog (ENAH), identified as an OSCC progression-associated protein, through proliferation, transwell migration, and invasion assays in OSCC cells. The mechanisms underlying ENAH-mediated functions were elucidated using gene knockdown and ectopic expression techniques in OSCC cells.
ENAH was identified as a candidate associated with OSCC progression based on integrated analyses, which showed increased ENAH levels in primary OSCC tissues compared with adjacent noncancerous counterparts, and sustained overexpression in the cancer tissues of PDX models. We confirmed that level of ENAH is increased in OSCC tissues and that its elevated expression correlates with poorer survival rates in patients with OSCC. Furthermore, the upregulation of ENAH in OSCC cells results from the activation of the GSK3β/β-catenin axis by the EGFR/PI3K/AKT cascade. ENAH expression enhances cell proliferation and mobility by upregulating integrin β5 in oral cancer cells.
The upregulation of ENAH through a PI3K/AKT/β-catenin signaling cascade enhances oral cancer cell migration and growth via the ITGB5/Src axis. These findings offer a new interpretation of the ENAH function in the OSCC progression and provide crucial information for developing new OSCC treatment strategies. |
---|---|
AbstractList | Oral cancer accounts for 2% of cancer-related deaths globally, with over 90% of cases being oral cavity squamous cell carcinomas (OSCCs). Approximately 50% of patients with OSCC succumb to the disease within 5 years, primarily due to the advanced stage at which it is typically diagnosed. This underscores an urgent need to identify proteins related to OSCC progression to develop effective diagnostic and therapeutic strategies.BACKGROUNDOral cancer accounts for 2% of cancer-related deaths globally, with over 90% of cases being oral cavity squamous cell carcinomas (OSCCs). Approximately 50% of patients with OSCC succumb to the disease within 5 years, primarily due to the advanced stage at which it is typically diagnosed. This underscores an urgent need to identify proteins related to OSCC progression to develop effective diagnostic and therapeutic strategies.To identify OSCC progression-related proteins, we conducted integrated proteome and transcriptome analyses on cancer tissues from patients and patient-derived xenograft (PDX) model mice. We investigated the role of protein-enabled homolog (ENAH), identified as an OSCC progression-associated protein, through proliferation, transwell migration, and invasion assays in OSCC cells. The mechanisms underlying ENAH-mediated functions were elucidated using gene knockdown and ectopic expression techniques in OSCC cells.METHODSTo identify OSCC progression-related proteins, we conducted integrated proteome and transcriptome analyses on cancer tissues from patients and patient-derived xenograft (PDX) model mice. We investigated the role of protein-enabled homolog (ENAH), identified as an OSCC progression-associated protein, through proliferation, transwell migration, and invasion assays in OSCC cells. The mechanisms underlying ENAH-mediated functions were elucidated using gene knockdown and ectopic expression techniques in OSCC cells.ENAH was identified as a candidate associated with OSCC progression based on integrated analyses, which showed increased ENAH levels in primary OSCC tissues compared with adjacent noncancerous counterparts, and sustained overexpression in the cancer tissues of PDX models. We confirmed that level of ENAH is increased in OSCC tissues and that its elevated expression correlates with poorer survival rates in patients with OSCC. Furthermore, the upregulation of ENAH in OSCC cells results from the activation of the GSK3β/β-catenin axis by the EGFR/PI3K/AKT cascade. ENAH expression enhances cell proliferation and mobility by upregulating integrin β5 in oral cancer cells.RESULTSENAH was identified as a candidate associated with OSCC progression based on integrated analyses, which showed increased ENAH levels in primary OSCC tissues compared with adjacent noncancerous counterparts, and sustained overexpression in the cancer tissues of PDX models. We confirmed that level of ENAH is increased in OSCC tissues and that its elevated expression correlates with poorer survival rates in patients with OSCC. Furthermore, the upregulation of ENAH in OSCC cells results from the activation of the GSK3β/β-catenin axis by the EGFR/PI3K/AKT cascade. ENAH expression enhances cell proliferation and mobility by upregulating integrin β5 in oral cancer cells.The upregulation of ENAH through a PI3K/AKT/β-catenin signaling cascade enhances oral cancer cell migration and growth via the ITGB5/Src axis. These findings offer a new interpretation of the ENAH function in the OSCC progression and provide crucial information for developing new OSCC treatment strategies.CONCLUSIONSThe upregulation of ENAH through a PI3K/AKT/β-catenin signaling cascade enhances oral cancer cell migration and growth via the ITGB5/Src axis. These findings offer a new interpretation of the ENAH function in the OSCC progression and provide crucial information for developing new OSCC treatment strategies. BackgroundOral cancer accounts for 2% of cancer-related deaths globally, with over 90% of cases being oral cavity squamous cell carcinomas (OSCCs). Approximately 50% of patients with OSCC succumb to the disease within 5 years, primarily due to the advanced stage at which it is typically diagnosed. This underscores an urgent need to identify proteins related to OSCC progression to develop effective diagnostic and therapeutic strategies.MethodsTo identify OSCC progression-related proteins, we conducted integrated proteome and transcriptome analyses on cancer tissues from patients and patient-derived xenograft (PDX) model mice. We investigated the role of protein-enabled homolog (ENAH), identified as an OSCC progression-associated protein, through proliferation, transwell migration, and invasion assays in OSCC cells. The mechanisms underlying ENAH-mediated functions were elucidated using gene knockdown and ectopic expression techniques in OSCC cells.ResultsENAH was identified as a candidate associated with OSCC progression based on integrated analyses, which showed increased ENAH levels in primary OSCC tissues compared with adjacent noncancerous counterparts, and sustained overexpression in the cancer tissues of PDX models. We confirmed that level of ENAH is increased in OSCC tissues and that its elevated expression correlates with poorer survival rates in patients with OSCC. Furthermore, the upregulation of ENAH in OSCC cells results from the activation of the GSK3β/β-catenin axis by the EGFR/PI3K/AKT cascade. ENAH expression enhances cell proliferation and mobility by upregulating integrin β5 in oral cancer cells.ConclusionsThe upregulation of ENAH through a PI3K/AKT/β-catenin signaling cascade enhances oral cancer cell migration and growth via the ITGB5/Src axis. These findings offer a new interpretation of the ENAH function in the OSCC progression and provide crucial information for developing new OSCC treatment strategies. Abstract Background Oral cancer accounts for 2% of cancer-related deaths globally, with over 90% of cases being oral cavity squamous cell carcinomas (OSCCs). Approximately 50% of patients with OSCC succumb to the disease within 5 years, primarily due to the advanced stage at which it is typically diagnosed. This underscores an urgent need to identify proteins related to OSCC progression to develop effective diagnostic and therapeutic strategies. Methods To identify OSCC progression-related proteins, we conducted integrated proteome and transcriptome analyses on cancer tissues from patients and patient-derived xenograft (PDX) model mice. We investigated the role of protein-enabled homolog (ENAH), identified as an OSCC progression-associated protein, through proliferation, transwell migration, and invasion assays in OSCC cells. The mechanisms underlying ENAH-mediated functions were elucidated using gene knockdown and ectopic expression techniques in OSCC cells. Results ENAH was identified as a candidate associated with OSCC progression based on integrated analyses, which showed increased ENAH levels in primary OSCC tissues compared with adjacent noncancerous counterparts, and sustained overexpression in the cancer tissues of PDX models. We confirmed that level of ENAH is increased in OSCC tissues and that its elevated expression correlates with poorer survival rates in patients with OSCC. Furthermore, the upregulation of ENAH in OSCC cells results from the activation of the GSK3β/β-catenin axis by the EGFR/PI3K/AKT cascade. ENAH expression enhances cell proliferation and mobility by upregulating integrin β5 in oral cancer cells. Conclusions The upregulation of ENAH through a PI3K/AKT/β-catenin signaling cascade enhances oral cancer cell migration and growth via the ITGB5/Src axis. These findings offer a new interpretation of the ENAH function in the OSCC progression and provide crucial information for developing new OSCC treatment strategies. Oral cancer accounts for 2% of cancer-related deaths globally, with over 90% of cases being oral cavity squamous cell carcinomas (OSCCs). Approximately 50% of patients with OSCC succumb to the disease within 5 years, primarily due to the advanced stage at which it is typically diagnosed. This underscores an urgent need to identify proteins related to OSCC progression to develop effective diagnostic and therapeutic strategies. To identify OSCC progression-related proteins, we conducted integrated proteome and transcriptome analyses on cancer tissues from patients and patient-derived xenograft (PDX) model mice. We investigated the role of protein-enabled homolog (ENAH), identified as an OSCC progression-associated protein, through proliferation, transwell migration, and invasion assays in OSCC cells. The mechanisms underlying ENAH-mediated functions were elucidated using gene knockdown and ectopic expression techniques in OSCC cells. ENAH was identified as a candidate associated with OSCC progression based on integrated analyses, which showed increased ENAH levels in primary OSCC tissues compared with adjacent noncancerous counterparts, and sustained overexpression in the cancer tissues of PDX models. We confirmed that level of ENAH is increased in OSCC tissues and that its elevated expression correlates with poorer survival rates in patients with OSCC. Furthermore, the upregulation of ENAH in OSCC cells results from the activation of the GSK3β/β-catenin axis by the EGFR/PI3K/AKT cascade. ENAH expression enhances cell proliferation and mobility by upregulating integrin β5 in oral cancer cells. The upregulation of ENAH through a PI3K/AKT/β-catenin signaling cascade enhances oral cancer cell migration and growth via the ITGB5/Src axis. These findings offer a new interpretation of the ENAH function in the OSCC progression and provide crucial information for developing new OSCC treatment strategies. |
ArticleNumber | 136 |
Author | Chang, Kai-Ping Hung, Chu-Mi Chan, Xiu-Ya Wu, Chih-Ching Yang, Chia-Yu Liu, Hao-Ping Huang, Chun-Chueh Liu, Chiao-Rou |
Author_xml | – sequence: 1 givenname: Xiu-Ya surname: Chan fullname: Chan, Xiu-Ya – sequence: 2 givenname: Kai-Ping surname: Chang fullname: Chang, Kai-Ping – sequence: 3 givenname: Chia-Yu surname: Yang fullname: Yang, Chia-Yu – sequence: 4 givenname: Chiao-Rou surname: Liu fullname: Liu, Chiao-Rou – sequence: 5 givenname: Chu-Mi surname: Hung fullname: Hung, Chu-Mi – sequence: 6 givenname: Chun-Chueh surname: Huang fullname: Huang, Chun-Chueh – sequence: 7 givenname: Hao-Ping surname: Liu fullname: Liu, Hao-Ping – sequence: 8 givenname: Chih-Ching orcidid: 0000-0002-7264-9672 surname: Wu fullname: Wu, Chih-Ching |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39511483$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkstu1DAUhi1URC_wAiyQJTZswvg-znKoSjtqBUhM19axYw8ZJfFgJ0B5LB6EZ8LTlAqxsn306dM5x_8pOhri4BF6SclbSrVaZEqV1BVhoiJESVqRJ-iEKl1XlNfs6J_7MTrNeUcII0KQZ-iY15JSofkJ-nm7T347dTC2ccAx4IsPqyts7zDgT2t-vVhdbxa_f1UORj-0A3aQHTQe71Ps4-gzjgm6Uh2cT9j5rsN9u02zDIYGb1P8Pn7B31ooT7zeXL6Ti8_JYfjR5ufoaYAu-xcP5xm6fX-xOb-qbj5ers9XN5UrnY-VZ5JTUMrLmiytbhraMKskyGVQIdSMUquWlhJJfGgUdc46KYQDAEqYDY6fofXsbSLszD61PaQ7E6E194WYtgbS2LrOG64VMC2Kqw6CEQaNFZbUXBFPglKkuN7MrrKAr5PPo-nbfJgbBh-nbDhlmjMhlCzo6__QXZzSUCY9UFIvmdB1oV49UJPtffPY3t8fKgCbAZdizsmHR4QSc4iBmWNgSgzMfQwM4X8AxOCiCw |
Cites_doi | 10.3389/fonc.2022.809589 10.1016/j.gene.2016.03.003 10.1038/s41568-019-0216-7 10.3389/fonc.2022.792297 10.1016/j.suronc.2019.09.001 10.1080/2162402X.2016.1221556 10.52586/4946 10.3390/ijerph17020665 10.3389/fonc.2020.00352 10.1038/srep35298 10.1158/1541-7786.MCR-15-0354 10.15252/embr.202050078 10.1038/s41419-019-1320-z 10.1007/s12094-018-02025-3 10.1186/s13045-020-01021-x 10.1002/cam4.6652 10.3892/ol.2016.5500 10.1073/pnas.2007213117 10.1155/2022/5501476 10.1242/jcs.220814 10.1038/s41467-017-00493-9 10.1038/s41419-018-1031-x 10.3892/etm.2010.171 10.1371/journal.pone.0037013 10.1038/s41392-023-01419-2 10.1002/cam4.4163 10.1091/mbc.e06-11-0990 10.1038/s41598-024-64264-5 10.1016/j.cell.2017.05.016 10.1016/j.cellsig.2020.109692 10.1073/pnas.1715998115 10.1038/s41392-021-00701-5 10.1186/s12964-023-01264-4 10.3389/fonc.2022.1052375 10.1158/1078-0432.CCR-07-1041 10.1038/s41388-018-0364-3 10.1007/s12551-013-0124-0 10.1083/jcb.201003014 10.1080/21655979.2021.1977103 10.3389/fmolb.2020.590912 10.1093/narcan/zcaa021 10.1097/CM9.0000000000002108 10.1073/pnas.1214394109 10.1016/j.heliyon.2024.e28406 10.1074/mcp.RA119.001530 10.1038/s41392-022-01297-0 10.3389/fonc.2021.750852 10.1016/j.aca.2018.10.070 10.4103/jcar.JCar_17_18 10.3390/cancers12071726 10.1186/s13046-019-1091-5 10.3322/caac.21820 10.1158/1078-0432.CCR-05-2027 10.1146/annurev.cellbio.19.050103.103356 10.1016/j.bbagrm.2019.04.006 10.1161/ATVBAHA.110.206086 |
ContentType | Journal Article |
Copyright | 2024. The Author(s). The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2024. The Author(s). – notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88A 88E 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI 7X8 DOA |
DOI | 10.1186/s11658-024-00651-0 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Databases Natural Science Collection ProQuest One Community College ProQuest Central Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1689-1392 |
EndPage | 25 |
ExternalDocumentID | oai_doaj_org_article_386a2840509f4202adb4b09360e0f660 39511483 10_1186_s11658_024_00651_0 |
Genre | Journal Article |
GeographicLocations | United States--US Taiwan |
GeographicLocations_xml | – name: Taiwan – name: United States--US |
GrantInformation_xml | – fundername: Chang Gung Memorial Hospital, Linkou grantid: CMRPG3M0101 – fundername: Chang Gung Memorial Hospital, Linkou grantid: CLRPD1J0015 – fundername: National Science and Technology Council grantid: 111-2314-B-182A-078-MY3 – fundername: National Science and Technology Council grantid: 112-2320-B-182-044 – fundername: Chang Gung Memorial Hospital, Linkou grantid: BMRPC77 – fundername: Chang Gung Memorial Hospital, Linkou grantid: CMRPG3J1253 |
GroupedDBID | --- .86 .VR 06D 0R~ 0VY 29B 2JY 2~H 30V 4.4 408 53G 5GY 67N 67Z 6NX 6S1 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95. 95~ AAFWJ AAJSJ AAKDD AAQCX AASML AASQH AAXMT AAYXX ABAQN ABFKT ABMNI ABUWG ACGFS ACOMO ACPRK ACZBO ADBBV ADGYE ADOZN ADUKV AENEX AFBAA AFBBN AFCXV AFKRA AFPKN AFWTZ AHBYD AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AOIJS BA0 BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BHPHI BMC C6C CCPQU CITATION CS3 DU5 E3Z EBLON EBS EMOBN F5P FRP FYUFA G-Y G-Z GQ7 GROUPED_DOAJ GX1 HCIFZ HF~ HLICF HMCUK HMJXF HYE IJ- IXC IXE IY9 IZQ I~X I~Z KDC KOV M1P M7P MA- N9A OAM OK1 PF0 PHGZM PHGZT PIMPY PSQYO QOS R9I RBZ RNS ROL RPM RPX RSV S27 S3A S3B SBL SDH SHX SOJ T13 TR2 TSK TSV TUC U2A UKHRP VC2 WK8 XSB Y2W ~A9 CGR CUY CVF ECM EIF NPM PJZUB PPXIY PQGLB 3V. 7XB 88A 8FE 8FH 8FK AZQEC DWQXO GNUQQ K9. LK8 PKEHL PQEST PQQKQ PQUKI 7X8 PUEGO |
ID | FETCH-LOGICAL-c392t-e2531a66e5907b8dd1d2b65a57f6ff9211b67b1050efd61ccbc544caaa102bfc3 |
IEDL.DBID | DOA |
ISSN | 1689-1392 1425-8153 |
IngestDate | Wed Aug 27 01:27:49 EDT 2025 Fri Jul 11 04:10:28 EDT 2025 Fri Jul 25 19:24:28 EDT 2025 Mon Jul 21 06:07:18 EDT 2025 Tue Jul 01 03:25:18 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Integrin β5 (ITGB5) Oral cavity squamous cell carcinoma (OSCC) Patient-derived xenograft (PDX) GSK3β/β-catenin signaling Protein-enabled homolog (ENAH) Proteomics |
Language | English |
License | 2024. The Author(s). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c392t-e2531a66e5907b8dd1d2b65a57f6ff9211b67b1050efd61ccbc544caaa102bfc3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-7264-9672 |
OpenAccessLink | https://doaj.org/article/386a2840509f4202adb4b09360e0f660 |
PMID | 39511483 |
PQID | 3125872489 |
PQPubID | 54771 |
PageCount | 25 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_386a2840509f4202adb4b09360e0f660 proquest_miscellaneous_3128324465 proquest_journals_3125872489 pubmed_primary_39511483 crossref_primary_10_1186_s11658_024_00651_0 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-11-07 |
PublicationDateYYYYMMDD | 2024-11-07 |
PublicationDate_xml | – month: 11 year: 2024 text: 2024-11-07 day: 07 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Wrocław |
PublicationTitle | Cellular & molecular biology letters |
PublicationTitleAlternate | Cell Mol Biol Lett |
PublicationYear | 2024 |
Publisher | BioMed Central BMC |
Publisher_xml | – name: BioMed Central – name: BMC |
References | G Hoxhaj (651_CR20) 2020; 20 M Balsamo (651_CR35) 2016; 6 Y Yamada (651_CR27) 2018; 52 FA Ribeiro (651_CR55) 2014; 34 S Lakshminarayana (651_CR17) 2018; 17 S Li (651_CR21) 2023; 21 H Li (651_CR11) 2016; 14 Y Zhu (651_CR33) 2022; 2022 F Di Modugno (651_CR42) 2018; 37 WC Yen (651_CR10) 2022; 12 S Li (651_CR50) 2019; 1862 WC Huang (651_CR23) 2019; 38 F Di Modugno (651_CR49) 2012; 109 TW Chen (651_CR16) 2017; 8 L Zhou (651_CR28) 2022; 12 H Zhang (651_CR30) 2019; 10 L Satgunaseelan (651_CR53) 2021; 11 AA Molinolo (651_CR6) 2007; 13 A Najafov (651_CR19) 2012; 7 Y Zhang (651_CR31) 2021; 26 HW Chu (651_CR13) 2019; 18 F Guo (651_CR44) 2016; 584 C Xia (651_CR4) 2022; 135 Z Chi (651_CR29) 2024; 14 M Antoine (651_CR39) 2020; 73 N Ahuja (651_CR48) 2020; 2 CW Hsu (651_CR5) 2019; 1050 VA Jones (651_CR25) 2020; 10 RL Siegel (651_CR1) 2024; 74 M Barone (651_CR59) 2020; 117 R Melchionna (651_CR43) 2016; 5 SY Kao (651_CR3) 2015; 18 LC Hung (651_CR2) 2020; 17 Q Liu (651_CR32) 2021; 14 Y Liu (651_CR24) 2023; 8 L Zhang (651_CR58) 2019; 21 Y Ohnishi (651_CR18) 2017; 13 J Wang (651_CR34) 2021; 10 X Zhang (651_CR46) 2023; 12 LE Young (651_CR14) 2018; 131 L Liu (651_CR54) 2019; 31 EM Fabricius (651_CR57) 2011; 2 S Na (651_CR45) 2022; 12 LR Anderson (651_CR56) 2014; 6 J Xie (651_CR8) 2020; 7 B Ning (651_CR26) 2021; 12 F Di Modugno (651_CR41) 2006; 12 CY Yang (651_CR12) 2020; 12 SD Hansen (651_CR36) 2010; 191 DA Applewhite (651_CR40) 2007; 18 F Di Modugno (651_CR51) 2018; 115 R Nusse (651_CR47) 2017; 169 F Yu (651_CR9) 2021; 6 Q Li (651_CR7) 2023; 8 M Leifheit-Nestler (651_CR22) 2010; 30 R Melchionna (651_CR38) 2020; 21 HC Chang (651_CR52) 2024; 10 M Krause (651_CR37) 2003; 19 D Chen (651_CR15) 2018; 9 |
References_xml | – volume: 12 year: 2022 ident: 651_CR28 publication-title: Front Oncol doi: 10.3389/fonc.2022.809589 – volume: 584 start-page: 31 issue: 1 year: 2016 ident: 651_CR44 publication-title: Gene doi: 10.1016/j.gene.2016.03.003 – volume: 20 start-page: 74 issue: 2 year: 2020 ident: 651_CR20 publication-title: Nat Rev Cancer doi: 10.1038/s41568-019-0216-7 – volume: 12 year: 2022 ident: 651_CR10 publication-title: Front Oncol doi: 10.3389/fonc.2022.792297 – volume: 31 start-page: 90 year: 2019 ident: 651_CR54 publication-title: Surg Oncol doi: 10.1016/j.suronc.2019.09.001 – volume: 5 issue: 12 year: 2016 ident: 651_CR43 publication-title: Oncoimmunology doi: 10.1080/2162402X.2016.1221556 – volume: 26 start-page: 322 issue: 8 year: 2021 ident: 651_CR31 publication-title: Front Biosci doi: 10.52586/4946 – volume: 17 start-page: 665 issue: 2 year: 2020 ident: 651_CR2 publication-title: Int J Environ Res Public Health doi: 10.3390/ijerph17020665 – volume: 10 start-page: 352 year: 2020 ident: 651_CR25 publication-title: Front Oncol doi: 10.3389/fonc.2020.00352 – volume: 6 start-page: 35298 year: 2016 ident: 651_CR35 publication-title: Sci Rep doi: 10.1038/srep35298 – volume: 14 start-page: 278 issue: 3 year: 2016 ident: 651_CR11 publication-title: Mol Cancer Res doi: 10.1158/1541-7786.MCR-15-0354 – volume: 21 issue: 11 year: 2020 ident: 651_CR38 publication-title: EMBO Rep doi: 10.15252/embr.202050078 – volume: 10 start-page: 230 issue: 3 year: 2019 ident: 651_CR30 publication-title: Cell Death Dis doi: 10.1038/s41419-019-1320-z – volume: 21 start-page: 1052 issue: 8 year: 2019 ident: 651_CR58 publication-title: Clin Transl Oncol doi: 10.1007/s12094-018-02025-3 – volume: 14 start-page: 6 issue: 1 year: 2021 ident: 651_CR32 publication-title: J Hematol Oncol doi: 10.1186/s13045-020-01021-x – volume: 12 start-page: 20892 issue: 22 year: 2023 ident: 651_CR46 publication-title: Cancer Med doi: 10.1002/cam4.6652 – volume: 13 start-page: 930 issue: 2 year: 2017 ident: 651_CR18 publication-title: Oncol Lett doi: 10.3892/ol.2016.5500 – volume: 117 start-page: 29684 issue: 47 year: 2020 ident: 651_CR59 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.2007213117 – volume: 2022 start-page: 5501476 year: 2022 ident: 651_CR33 publication-title: J Immunol Res doi: 10.1155/2022/5501476 – volume: 131 start-page: jcs220814 issue: 21 year: 2018 ident: 651_CR14 publication-title: J Cell Sci doi: 10.1242/jcs.220814 – volume: 8 start-page: 465 issue: 1 year: 2017 ident: 651_CR16 publication-title: Nat Commun doi: 10.1038/s41467-017-00493-9 – volume: 9 start-page: 998 issue: 10 year: 2018 ident: 651_CR15 publication-title: Cell Death Dis doi: 10.1038/s41419-018-1031-x – volume: 2 start-page: 9 issue: 1 year: 2011 ident: 651_CR57 publication-title: Exp Ther Med doi: 10.3892/etm.2010.171 – volume: 7 issue: 5 year: 2012 ident: 651_CR19 publication-title: PLoS ONE doi: 10.1371/journal.pone.0037013 – volume: 8 start-page: 160 issue: 1 year: 2023 ident: 651_CR24 publication-title: Signal Transduct Target Ther doi: 10.1038/s41392-023-01419-2 – volume: 10 start-page: 6515 issue: 18 year: 2021 ident: 651_CR34 publication-title: Cancer Med doi: 10.1002/cam4.4163 – volume: 34 start-page: 1547 issue: 4 year: 2014 ident: 651_CR55 publication-title: Anticancer Res – volume: 18 start-page: 2579 issue: 7 year: 2007 ident: 651_CR40 publication-title: Mol Biol Cell doi: 10.1091/mbc.e06-11-0990 – volume: 14 start-page: 15023 issue: 1 year: 2024 ident: 651_CR29 publication-title: Sci Rep doi: 10.1038/s41598-024-64264-5 – volume: 18 start-page: 7 issue: 1 year: 2015 ident: 651_CR3 publication-title: Chin J Dent Res – volume: 169 start-page: 985 issue: 6 year: 2017 ident: 651_CR47 publication-title: Cell doi: 10.1016/j.cell.2017.05.016 – volume: 73 year: 2020 ident: 651_CR39 publication-title: Cell Signal doi: 10.1016/j.cellsig.2020.109692 – volume: 115 start-page: 3132 issue: 12 year: 2018 ident: 651_CR51 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1715998115 – volume: 6 start-page: 307 issue: 1 year: 2021 ident: 651_CR9 publication-title: Signal Transduct Target Ther doi: 10.1038/s41392-021-00701-5 – volume: 21 start-page: 266 issue: 1 year: 2023 ident: 651_CR21 publication-title: Cell Commun Signal doi: 10.1186/s12964-023-01264-4 – volume: 12 start-page: 1052375 year: 2022 ident: 651_CR45 publication-title: Front Oncol doi: 10.3389/fonc.2022.1052375 – volume: 13 start-page: 4964 issue: 17 year: 2007 ident: 651_CR6 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-07-1041 – volume: 37 start-page: 5605 issue: 42 year: 2018 ident: 651_CR42 publication-title: Oncogene doi: 10.1038/s41388-018-0364-3 – volume: 6 start-page: 203 issue: 2 year: 2014 ident: 651_CR56 publication-title: Biophys Rev doi: 10.1007/s12551-013-0124-0 – volume: 191 start-page: 571 issue: 3 year: 2010 ident: 651_CR36 publication-title: J Cell Biol doi: 10.1083/jcb.201003014 – volume: 12 start-page: 7907 issue: 1 year: 2021 ident: 651_CR26 publication-title: Bioengineered doi: 10.1080/21655979.2021.1977103 – volume: 7 year: 2020 ident: 651_CR8 publication-title: Front Mol Biosci doi: 10.3389/fmolb.2020.590912 – volume: 2 start-page: zcaa021 issue: 3 year: 2020 ident: 651_CR48 publication-title: NAR Cancer doi: 10.1093/narcan/zcaa021 – volume: 135 start-page: 584 issue: 5 year: 2022 ident: 651_CR4 publication-title: Chin Med J (Engl) doi: 10.1097/CM9.0000000000002108 – volume: 109 start-page: 19280 issue: 47 year: 2012 ident: 651_CR49 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1214394109 – volume: 10 issue: 6 year: 2024 ident: 651_CR52 publication-title: Heliyon doi: 10.1016/j.heliyon.2024.e28406 – volume: 18 start-page: 1796 issue: 9 year: 2019 ident: 651_CR13 publication-title: Mol Cell Proteomics doi: 10.1074/mcp.RA119.001530 – volume: 52 start-page: 166 issue: 1 year: 2018 ident: 651_CR27 publication-title: Int J Oncol – volume: 8 start-page: 31 issue: 1 year: 2023 ident: 651_CR7 publication-title: Signal Transduct Target Ther doi: 10.1038/s41392-022-01297-0 – volume: 11 year: 2021 ident: 651_CR53 publication-title: Front Oncol doi: 10.3389/fonc.2021.750852 – volume: 1050 start-page: 113 year: 2019 ident: 651_CR5 publication-title: Anal Chim Acta doi: 10.1016/j.aca.2018.10.070 – volume: 17 start-page: 7 year: 2018 ident: 651_CR17 publication-title: J Carcinog doi: 10.4103/jcar.JCar_17_18 – volume: 12 start-page: 1726 issue: 7 year: 2020 ident: 651_CR12 publication-title: Cancers doi: 10.3390/cancers12071726 – volume: 38 start-page: 89 issue: 1 year: 2019 ident: 651_CR23 publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-019-1091-5 – volume: 74 start-page: 12 issue: 1 year: 2024 ident: 651_CR1 publication-title: CA Cancer J, Clin doi: 10.3322/caac.21820 – volume: 12 start-page: 1470 issue: 5 year: 2006 ident: 651_CR41 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-05-2027 – volume: 19 start-page: 541 year: 2003 ident: 651_CR37 publication-title: Annu Rev Cell Dev Biol doi: 10.1146/annurev.cellbio.19.050103.103356 – volume: 1862 start-page: 858 issue: 8 year: 2019 ident: 651_CR50 publication-title: Biochim Biophys Acta Gene Regul Mech doi: 10.1016/j.bbagrm.2019.04.006 – volume: 30 start-page: 1398 issue: 7 year: 2010 ident: 651_CR22 publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.110.206086 |
SSID | ssj0020440 |
Score | 2.3723485 |
Snippet | Oral cancer accounts for 2% of cancer-related deaths globally, with over 90% of cases being oral cavity squamous cell carcinomas (OSCCs). Approximately 50% of... BackgroundOral cancer accounts for 2% of cancer-related deaths globally, with over 90% of cases being oral cavity squamous cell carcinomas (OSCCs).... Abstract Background Oral cancer accounts for 2% of cancer-related deaths globally, with over 90% of cases being oral cavity squamous cell carcinomas (OSCCs).... |
SourceID | doaj proquest pubmed crossref |
SourceType | Open Website Aggregation Database Index Database |
StartPage | 136 |
SubjectTerms | 1-Phosphatidylinositol 3-kinase AKT protein Animal models Animals beta Catenin - genetics beta Catenin - metabolism Cell activation Cell culture Cell Line, Tumor Cell migration Cell Movement - genetics Cell proliferation Cell Proliferation - genetics Cell survival Clinical trials Ectopic expression Epidermal growth factor Female Gene Expression Regulation, Neoplastic GSK3β/β-catenin signaling Head & neck cancer Humans Immunohistochemistry Integrin beta Chains - genetics Integrin beta Chains - metabolism Integrin β5 (ITGB5) Male Mass spectrometry Medical prognosis Medical research Metastasis Mice Mice, Nude Mouth Neoplasms - genetics Mouth Neoplasms - metabolism Mouth Neoplasms - pathology Oral cancer Oral carcinoma Oral cavity Oral cavity squamous cell carcinoma (OSCC) Patient-derived xenograft (PDX) Patients Peptides Phosphatidylinositol 3-Kinases - genetics Phosphatidylinositol 3-Kinases - metabolism Protein-enabled homolog (ENAH) Proteins Proteomes Proteomics Proto-Oncogene Proteins c-akt - genetics Proto-Oncogene Proteins c-akt - metabolism Ratios Scientific imaging Signal Transduction Software Squamous cell carcinoma Src protein src-Family Kinases - genetics src-Family Kinases - metabolism Transcriptomes Tumors Up-regulation Up-Regulation - genetics β-Catenin |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCIkL4s2WgozEDVnxJrbjnFCLWrYgKiS60t4sv7LdA8mSbCvKz-KH8JuYcbJbcYBjHMuK5uH5ZjIPQt4UgLHdNIJb4oJlQrqSVUJzZhX3RVkGFzkWJ38-U7O5-LiQizHg1o9plds7MV3UofUYI88KsMS6zIWu3q2_M5wahX9XxxEat8kdbF2GUl0ubhwuHKecqotyyTSo9rZoRqusx7YzmoGFYmiFwaX-yzCl_v3_Bp3J-Jw8IPdH1EgPBzY_JLdi84jcHeZIXj8mP-frbpgpD1SmbU2Pzw5n1F1TS7-cFp8yAHLZ718Mk5-aVUO97TErnq5TKl7sKVbpwyrwv6MYyaffVstBMqhtAl2Cq765oFcrC4_09PzDkcy-dp7aH6v-CZmfHJ-_n7FxqALzAIU2LOagdVapKMEtdjqEacidklaWtarrCvxBp0oHqIvHOqip985LIby1FqCIq33xlOw1bROfEyqsrNC2cSutCJFrp7wOTlqtVK55NSFvtxQ166F3hkk-h1ZmoL8B-ptEf8Mn5AiJvtuJfa_TQtstzahGptDKgkHFpjW1yHlugxOOV4XikddKwSEHW5aZURl7cyM6E_J69xrUCClqm9hepj1wt2H3uAl5NrB69yUFoFDwGov9_x_-gtzLUZ4w5lwekL1NdxlfAmLZuFdJLP8AuFTk-g priority: 102 providerName: ProQuest |
Title | Upregulation of ENAH by a PI3K/AKT/β-catenin cascade promotes oral cancer cell migration and growth via an ITGB5/Src axis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39511483 https://www.proquest.com/docview/3125872489 https://www.proquest.com/docview/3128324465 https://doaj.org/article/386a2840509f4202adb4b09360e0f660 |
Volume | 29 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NbxMxELWgCIlLxTcpJTISN2Sts2t7nWODUlIQUVUaKeJijT-25NBNlE0rys_qD-lvYrzeRHBAXListLs-jN7Ynves8Qwh7wrk2HYQUJZYD0xIW7Kh0JyB4q4oS28Dj5eTv0zVZCY-zeX8t1ZfMScslQdOwGWFVoBbaCxTUglU6uCtsCjDFQ-8UqpV6xjztmKqk1qxkfL2ioxWWROLzGiG8YjFmIsC-o8w1Fbr_zvFbEPN8WOy33FEepRse0LuhfopeZi6Rt48Iz9nq3XqII-Y0mVFx9OjCbU3FOjpSfE5Q9qW3d2ymOpUL2rqoIk58HTVJt6FhsY7-fgVvb2m8dyeXi4u0jygUHt6gcJ8851eLwBf6cn5x5HMvq4dhR-L5jmZHY_PP0xY10KBOSQ-GxZyXGOgVJAogq32fuBzqyTIslJVNUT1Z1VpkWPxUHk1cM46KYQDACQetnLFC7JXL-vwilABchgjGQcJwgeurXLaWwlaqVzzYY-83yJqVqlShmkVhlYm4W8Qf9Pib3iPjCLou5GxynX7AX1vOt-bf_m-Rw63LjPd0mtMgZRNl7nQaNHb3W9cNBFRqMPyqh2DO1msFdcjL5Ord5YUyDlRIxYH_8PC1-RRHmddPIcuD8neZn0V3iCL2dg-uV_Oyz55MBpPT8_67fTF59no2y9ap-2X |
linkProvider | Directory of Open Access Journals |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NjtMwELaWRQguiH8KCxgJTsiK68SOc0BoF3Zp6W6FRCv15vVfSg8kJemylIfiwIPwTIyTpisOcNtjHMuKZsbzzRePZxB6EUOMbfoeaIlxmiTcpCRLJCVaUBunqTOehsvJJ2MxmCYfZny2g352d2FCWmXnExtH7Uob_pFHMSCxTFkiszfLryR0jQqnq10LjdYsRn59DpStfj18B_p9ydjR4eTtgGy6ChALscCKeAZmp4XwHHihkc71HTOCa57mIs8zIERGpAbCDupzJ_rWGsuTxGqtAYtNbmNY9wq6CsBLA9lLZxcEL7Rvbm4zMU4kuJLuko4UUR3K3EgCiEgC6gOF_wsIm34B_w5yG7A7uoVubqJUvN-a1W2044s76Frbt3J9F_2YLqu2hz1oFZc5PhzvD7BZY40_DuNRBIFj9PsXCclWxaLAVtchCx8vm9Q_X-NQFQBGwd4qHE4O8JfFvLVErAuH51V5vvqMvy00POLh5P0Bjz5VFuvvi_oeml6KuO-j3aIs_EOEE82zgKVUc504T6URVjrDtRSCSZr10KtOomrZ1upQDceRQrXyVyB_1chf0R46CELfzgx1tpuBspqrzbZVsRQaADwUyckTRpl2JjE0iwX1NBcCFtnrVKY2m79WF6baQ8-3r2HbBonqwpdnzRzwpaFaXQ89aFW9_ZIYol5gqfGj_y_-DF0fTE6O1fFwPHqMbrBgW-F_d7qHdlfVmX8C0dLKPG1MFKPTy94TfwBQ3yLy |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lj9MwELaWrkBcEG8KCxgJTsiKm8SOc0Boy7a0FKoKdqW9Gb9SeiApSZel_CyO_Ah-E-M8ijjAbY9xLCuaGc98XzyeQehpBBhbDxzQEm0ViZlOSBoLShSnJkoSqx31l5PfzfnkJH5zyk730M_uLoxPq-x8Yu2obWH8P_IggkgskjAWaZC1aRGLo_HL9RfiO0j5k9aunUZjIjO3PQf6Vr2YHoGun4XheHT8akLaDgPEAC7YEBeCCSrOHQOOqIW1AxtqzhRLMp5lKZAjzRMNEIS6zPKBMdqwODZKKYjLOjMRrHsJ7SeeFfXQ_nA0X7zf0T3fzLm-2xQyIsCxdFd2BA8qX_RGEIiPxGMAIPR_hcW6e8C_IW8d-sbX0bUWs-LDxshuoD2X30SXmy6W21vo-8m6bDrag45xkeHR_HCC9RYrvJhGswBgZPDrB_GpV_kqx0ZVPicfr-tEQFdhXyMARsH6SuzPEfDn1bKxS6xyi5dlcb75hL-uFDzi6fHrIQs-lAarb6vqNjq5EIHfQb28yN09hGPFUh9ZqWIqto4KzY2wminBeSho2kfPO4nKdVO5Q9aMR3DZyF-C_GUtf0n7aOiFvpvpq27XA0W5lO0mlpHgCsK5L5mTxSENldWxpmnEqaMZ57DIQacy2bqCSv4x3D56snsNm9hLVOWuOKvngGf1tev66G6j6t2XRICBgbNG9_-_-GN0BfaDfDudzx6gq6E3Lf_zOzlAvU155h4CdNroR62NYvTxorfFb_5PKI0 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Upregulation+of+ENAH+by+a+PI3K%2FAKT%2F%CE%B2-catenin+cascade+promotes+oral+cancer+cell+migration+and+growth+via+an+ITGB5%2FSrc+axis&rft.jtitle=Cellular+%26+molecular+biology+letters&rft.au=Chan%2C+Xiu-Ya&rft.au=Chang%2C+Kai-Ping&rft.au=Yang%2C+Chia-Yu&rft.au=Liu%2C+Chiao-Rou&rft.date=2024-11-07&rft.issn=1689-1392&rft.eissn=1689-1392&rft.volume=29&rft.issue=1&rft.spage=136&rft_id=info:doi/10.1186%2Fs11658-024-00651-0&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1689-1392&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1689-1392&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1689-1392&client=summon |